| Term | Count | % | | TREATMENT FAILURE | 5910 | 7.18% |
| DRUG INEFFECTIVE | 3137 | 3.81% |
| EYE IRRITATION | 2396 | 2.91% |
| FATIGUE | 2166 | 2.63% |
| INTRAOCULAR PRESSURE INCREASED | 1830 | 2.22% |
| HEADACHE | 1736 | 2.11% |
| EYE PAIN | 1722 | 2.09% |
| DYSPNOEA | 1589 | 1.93% |
| VISION BLURRED | 1584 | 1.93% |
| DEATH | 1583 | 1.92% |
| DIZZINESS | 1557 | 1.89% |
| DIARRHOEA | 1533 | 1.86% |
| NAUSEA | 1506 | 1.83% |
| OFF LABEL USE | 1493 | 1.81% |
| OCULAR HYPERAEMIA | 1437 | 1.75% |
| FALL | 1372 | 1.67% |
| CATARACT | 1357 | 1.65% |
| GLAUCOMA | 1334 | 1.62% |
| PAIN | 1233 | 1.50% |
| ASTHENIA | 1232 | 1.50% |
| HYPERSENSITIVITY | 1156 | 1.41% |
| RASH | 988 | 1.20% |
| MALAISE | 987 | 1.20% |
| VISUAL IMPAIRMENT | 987 | 1.20% |
| PNEUMONIA | 944 | 1.15% |
| PRURITUS | 915 | 1.11% |
| WEIGHT DECREASED | 914 | 1.11% |
| CONDITION AGGRAVATED | 901 | 1.10% |
| PAIN IN EXTREMITY | 882 | 1.07% |
| ARTHRALGIA | 880 | 1.07% |
| COUGH | 854 | 1.04% |
| VOMITING | 832 | 1.01% |
| HYPERTENSION | 822 | 1.00% |
| EYE PRURITUS | 785 | 0.95% |
| DRUG HYPERSENSITIVITY | 753 | 0.92% |
| VISUAL ACUITY REDUCED | 730 | 0.89% |
| CONSTIPATION | 703 | 0.85% |
| DRY EYE | 701 | 0.85% |
| INSOMNIA | 676 | 0.82% |
| PYREXIA | 667 | 0.81% |
| PRODUCT DOSE OMISSION ISSUE | 662 | 0.80% |
| CONFUSIONAL STATE | 660 | 0.80% |
| EYE DISORDER | 652 | 0.79% |
| DECREASED APPETITE | 623 | 0.76% |
| DEPRESSION | 622 | 0.76% |
| BACK PAIN | 609 | 0.74% |
| PRODUCT QUALITY ISSUE | 597 | 0.73% |
| CEREBROVASCULAR ACCIDENT | 584 | 0.71% |
| ACUTE KIDNEY INJURY | 583 | 0.71% |
| URINARY TRACT INFECTION | 567 | 0.69% |
| SOMNOLENCE | 565 | 0.69% |
| GAIT DISTURBANCE | 548 | 0.67% |
| ANAEMIA | 546 | 0.66% |
| INCORRECT DOSE ADMINISTERED | 533 | 0.65% |
| ANXIETY | 516 | 0.63% |
| BLOOD PRESSURE INCREASED | 516 | 0.63% |
| HYPOTENSION | 514 | 0.62% |
| FEELING ABNORMAL | 512 | 0.62% |
| CHEST PAIN | 511 | 0.62% |
| LACRIMATION INCREASED | 511 | 0.62% |
| ERYTHEMA | 496 | 0.60% |
| PALPITATIONS | 492 | 0.60% |
| ABDOMINAL DISCOMFORT | 484 | 0.59% |
| COVID-19 | 477 | 0.58% |
| BLINDNESS | 466 | 0.57% |
| MYALGIA | 460 | 0.56% |
| ATRIAL FIBRILLATION | 447 | 0.54% |
| PERIPHERAL SWELLING | 447 | 0.54% |
| PRODUCT USE ISSUE | 439 | 0.53% |
| DRUG INTOLERANCE | 437 | 0.53% |
| ARTHRITIS | 435 | 0.53% |
| MUSCLE SPASMS | 435 | 0.53% |
| NASOPHARYNGITIS | 431 | 0.52% |
| RENAL FAILURE | 431 | 0.52% |
| PRODUCT USE IN UNAPPROVED INDICATION | 428 | 0.52% |
| TREMOR | 428 | 0.52% |
| HAEMOGLOBIN DECREASED | 422 | 0.51% |
| OEDEMA PERIPHERAL | 420 | 0.51% |
| ABDOMINAL PAIN UPPER | 399 | 0.49% |
| ALOPECIA | 395 | 0.48% |
| ABDOMINAL PAIN | 392 | 0.48% |
| INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION | 388 | 0.47% |
| BRONCHITIS | 386 | 0.47% |
| DEHYDRATION | 385 | 0.47% |
| WEIGHT INCREASED | 384 | 0.47% |
| EYE SWELLING | 383 | 0.47% |
| MUSCULAR WEAKNESS | 378 | 0.46% |
| FOREIGN BODY SENSATION IN EYES | 362 | 0.44% |
| MYOCARDIAL INFARCTION | 361 | 0.44% |
| SYNCOPE | 359 | 0.44% |
| MEMORY IMPAIRMENT | 354 | 0.43% |
| DYSGEUSIA | 345 | 0.42% |
| BALANCE DISORDER | 342 | 0.42% |
| WRONG TECHNIQUE IN PRODUCT USAGE PROCESS | 342 | 0.42% |
| PARAESTHESIA | 341 | 0.41% |
| HYPOAESTHESIA | 339 | 0.41% |
| BLOOD GLUCOSE INCREASED | 338 | 0.41% |
| CARDIAC FAILURE CONGESTIVE | 334 | 0.41% |
| VERTIGO | 334 | 0.41% |
| ASTHMA | 331 | 0.40% |
| Total | 82262 | |